Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction CBAN Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Alcon Inc Ordinary Shares ALC Q1 2026 Earnings EPS Beat Drives Optimism but Stock Edges Lower C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline CVLG Q1 2026 Earnings EPS Misses Estimates as Profitability Pressures Persist EOSE Q1 2026 Earnings EPS Beats Estimates by 188 as Stock Surges